U.S. Stocks Little Changed on Greek Deal

U.S. stocks were little changed, a day after the Standard & Poor’s 500 Index rose to a seven-month high, as investors weighed an agreement by Greek political leaders on measures needed to secure international rescue funds.

“The market is very, very tenuous,” Michael Crofton, chief executive officer at Philadelphia Trust Co., said in a telephone interview. His firm manages about $1.7 billion. “Austerity is the opposite of growth. Austerity could force Greece into a depression, which would force them back to the table to ask for more aid. The ECB is caught between a rock and a hard place. They need to play their cards close to the vest until they are sure this quasi-solution for Greece will stick.”

Greece’s government reached a deal on austerity measures required for a 130 billion-euro ($173 billion) financing package, according to an e-mailed statement from the Greek Prime Minister’s press office. European Central Bank President Mario Draghi signaled the economic outlook has improved, suggesting policy makers may be less inclined to add to stimulus.

Read More >>

Yesterday’s Top Performing Small Cap Stock:

Marley Coffee (OTCBB: JAMN)

Marley Coffee was a SmallCapVoice top performer closing up over 26% on trading volume of 1,863,317 shares.

Marley Coffee is a US-based company providing premium-roasted coffee to the Grocery, Retail, Online, Service/Hospitality, Office Coffee Service, and Big Box Store industries. Under its exclusive licensing agreement with 56 Hope Road (Bob Marley Museum), the Company continues to develop its coffee lines under the Marley Coffee brand.

Marley Coffee’s gourmet product line is positioned for the significant trend and growing consumer awareness towards organic, fairly traded premium, and super premium specialty coffees.

Read More >>

Today’s SmallCapVoice.com Hot Stock to Watch:

PositiveID Corporation (OTCBB: PSID)

A New Audio Interview with PositiveID Chairman and CEO, William J. Caragol, is now at SmallCapVoice.com

AUSTIN, Texas, Feb. 9, 2012 /PRNewswire/ — SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation (OTCBB: PSID), a developer of medical technologies for diabetes management, is now available. The interview can be heard at http://smallcapvoice.com/blog/2-8-12-smallcapvoice-interview-with-positiveid-corporation-otcbb-psid.

Read More >>

Attitude Drinks Incorporated (OTCBB: ATTD)

Attitude Drinks Announces Brown Distributing Company to Distribute Phase III® Recovery

PALM BEACH GARDENS, Fla., Feb. 9, 2012 /PRNewswire/ — Attitude Drinks (OTC.BB:ATTD) (OTCQB: ATTD), an innovative beverage brand development company and creator of the Phase III® Recovery brand, today announced a distribution agreement with Brown Distributing Company to service Phase III® throughout 269 Walgreens locations. Phase III® will be distributed by Brown in southeast Florida from Palm Beach County through Broward, Miami-Dade and Monroe counties to the Florida Keys.

Read More >>

Other Small Cap News

ProPhotonix Limited (Pink Sheets: STKR)

ProPhotonix Adds New HL65051DG Laser Diode From Opnext to Its Laser Diode Line-Up

HL65051DG Provides High Power Single-Mode 660nm Output With Built-In Photodiode

SALEM, N.H., Feb. 9, 2012 (GLOBE NEWSWIRE) — ProPhotonix Limited, (OTC:STKR), a designer and manufacturer of LED light engines and laser diode modules as well as a distributor of premium laser diodes, is pleased to announce that they are adding the HL65051DG laser diode from Opnext, Inc. to the wide range of diodes ProPhotonix offers. This new laser diode gives system designers and OEMs the highest power single-mode laser on the market at this wavelength in a package that includes an integrated monitor photodiode.

Read More >>

China Nutrifruit Group Limited (NYSE Amex: CNGL)

China Nutrifruit Schedules Conference Call to Discuss Third Quarter Fiscal Year 2012 Results

DAQING, Heilongjiang Province, China, Feb. 9, 2012 /PRNewswire-Asia-FirstCall/ — China Nutrifruit Group Limited, (NYSE AMEX: CNGL) (“China Nutrifruit” or “the Company”), a leading producer of premium specialty fruit based products in China, today announced that it will host a conference call at 9:00 a.m. Eastern Time on Monday, February 13, 2012, to discuss financial results for the third quarter fiscal year 2012 ended December 31, 2011.

Read More >>

Lyris, Inc. (OTCBB: LYRI)

Lyris, Inc., Reports Second Quarter 2012 Results

EMERYVILLE, Calif., Feb. 9, 2012 (GLOBE NEWSWIRE) — Lyris, Inc., (OTCBB:LYRI), the global digital marketing expert, today reported results for the second quarter and first six months of fiscal 2012.

For the quarter ended December 31, 2011, Lyris reported revenues of $10.6 million, compared to revenues of $10.3 million in the same period a year ago and $9.7 million in the prior quarter.

Read More >>

eCrypt Technologies (OTCBB: ECRY)

eCrypt Email Encryption for iPhone Available on iTunes

eCrypt Launches eCrypt Me App for iPhone

“We’ve received many inquiries asking when we would have a product available for the iPhone, and while eCrypt Me’s web interface is completely accessible by all mobile devices via the web browser, we understand that iPhone users prefer apps, and we’re very happy to offer a security solution to iPhone users that’s as easy to use as email,” says Brad Lever, eCrypt CEO. “This is the first of a series of smartphone apps we plan to roll out this year.”

Read More >>

Beacon Enterprise Solutions (OTCBB: BEAC)

Beacon Enterprise Solutions Reports 51% Increase in Net Sales and 97% Increase in Gross Profit for Fiscal First Quarter 2012

Income from Operations Increases by $1.5 Million Year over Year

Bruce Widener, Chairman and CEO of Beacon Enterprise Solutions commented, ” We are currently on track to achieve a minimum of 50% annual sales growth in 2012, without the benefit of pending large infrastructure projects, and expect to achieve sustainable profitability. Our sales pipeline remains robust and continues to expand. We are also continuing to pursue a number of large project opportunities that could have a significant, positive impact on our growth and profitability in 2012.”

Read More >>

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide. Known for its ability to help emerging growth companies build a following among retail and institutional investors, SmallCapVoice.com utilizes its stock newsletter to feature its audio interviews, as well small cap company’s financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our company information sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.

IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks

Contact:

Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
http://www.smallcapvoice.com

Roy Warren, CEO of Attitude Drinks, commented, “Our agreements with great beverage distribution companies like Brown with their superior reputation in customer service are the foundation of our sales opportunity in Walgreens and many other retail accounts in Florida.”

Jack Shea, Executive Vice President Sales, said: “We are delighted to be working with such a strong distributor as Brown Distributors in Florida. The recent authorization of Phase III® Recovery in Walgreens requires excellence in sales and distribution organization to the stores. Brown is a leader in the sales and distribution of non-alcoholic beverages.

About Attitude Drinks:

Attitude Drinks, Inc. is an innovative, beverage brand development company with a pure milk recovery drink that exploits recent scientific evidence confirming the benefits of milk and protein as an exercise recovery aid. Phase III® is sold in select local, regional and national markets, including colleges, universities, convenience stores, fitness centers and gyms, as well as online. For more information, including recent clinical trial results, visit www.attitudedrinks.com.

This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the failure to meet schedule or performance requirements of the Company’s contracts, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In light of these uncertainties, the forward-looking events referred to in this release might not occur.

Contact:
Roy Warren, CEO
Attitude Drinks, Inc.
561.227.2727
roy@attitudedrinks.com
www.attitudedrinks.com

SOURCE Attitude Drinks, Inc.

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

About PositiveID Corporation

PositiveID Corporation develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MicroFluidic Systems, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit www.PositiveIDCorp.com.

Statements about PositiveID’s future expectations, including forward looking statements in PositiveID’s interview with SmallCapVoice.com relating to its diabetes management products, molecular diagnostics and homeland defense products, and all other statements in this press release and PositiveID’s interview with SmallCapVoice.com other than historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include PositiveID’s ability to successfully complete development of and commercialize its diabetes management product, molecular diagnostic systems products and homeland defense products; as well as certain other risks. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

Contact:

Allison Tomek
561-805-8000
atomek@positiveidcorp.com

Contact for SmallCapVoice.com:

Stuart T. Smith
512-267-2430
info@smallcapvoice.com

Source: SmallCapVoice.com

PositiveID Chairman and CEO William J. Caragol, called into SmallCapVoice.com to go over the business model and market for the Company’s exciting product lines.  PositiveID Corporation (OTCBB: PSID) develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.

For more information on iglucose, please visit http://www.iglucose.com. For sales and partnership opportunities, please contact Mary Ellen Harrison at 561-805-8028 ormeharrison@positiveidcorp.com.

Wall Street edges up on Greece, Disney earnings

Stocks edged higher on Wednesday as hopeful investors awaited the latest attempt by Greece to reach a deal on reforms in exchange for a new bailout.

The delays stirred European Union officials to warn Greece the euro zone could continue without the fiscally troubled nation, which needs a rescue package to avoid an unruly default.

"They are pretty close on the debt talks, and it looks like the prime minister is getting the various members of his coalition in line (so) that they may actually get this done," said Peter Jankovskis, co-chief investment officer at OakBrook Investments LLC in Lisle, Illinois.

"These folks have been at it for a very long time. They have been fighting with this issue for about eighteen months, so they really do see this as, ‘We have to get it right this time.’"

Read More >>

Yesterday’s Top Performing Small Cap Stock:

Attitude Drinks Incorporated (OTCBB: ATTD)

Attitude Drinks Incorporated was a SmallCapVoice top performer closing up over 11% on trading volume of 10,154,211 shares.

Attitude Drinks Inc. is an innovative beverage brand development company with pure milk-based recovery drink that exploits recent scientific evidence confirming the benefits of milk and protein as an exercise recovery aid. Phase III is sold in select local, regional and national markets, including colleges, universities, convenience stores, fitness centers and gyms, as well as online.

Read More >>

Today’s SmallCapVoice.com Hot Stock to Watch:

PositiveID Corporation (OTCBB: PSID)

PositiveID Corporation Announces Initiation of Clinical Trial of Its Easy Check Non-Invasive Breath Glucose Detection Device

Independent Clinical Trial to Run for a Period of Six Months and Focus on People With Type 1 Diabetes

Currently under development in Israel, Easy Check is a non-invasive breath glucose detection device that measures the level of acetone in a patient’s exhaled breath and correlates that acetone level to a measure of blood glucose. The Easy Check technology is based on a patent-pending reagent cell that mixes a patient’s exhaled air with a proprietary chemical compound, triggering a chemical reaction. The reaction is measured and software in the Easy Check device then interprets the measurement and correlates the patient’s acetone level to the level of glucose in the body. The goal of Easy Check is to eliminate a patient’s need to prick his or her finger multiple times per day to get a blood sugar reading.

Read More >>

Viper Networks, Inc. (Pink Sheets: VPER)

A New Audio Interview With Farid Shouekani, President and CEO of Viper Networks, Inc., Is now at SmallCapVoice.com

AUSTIN, Texas, Feb. 8, 2012 /PRNewswire/ — SmallCapVoice.com, Inc. announced today that a new audio interview with Viper Networks, Inc. (Pink Sheets: VPER) is now available. The interview can be heard at http://smallcapvoice.com/blog/2-6-12-smallcapvoice-interview-with-viper-networks-pink-sheets-vper

Read More >>

Other Small Cap News

Elray Resources Inc. (OTCBB: ELRA)

Elray Gaming Retains South Street Media as Public Relations Firm

Melissa J. Diaz, the President of South Street Media commented, "The recent changes from the US Dept. of Justice regarding online gaming set the stage for potential strong growth for the online gaming sector in the United States. South Street Media feels the firms that can establish their name, hold the technology, and have been compliant with the gaming laws in the past, have the best prospects to gain market share as new legislative rules become effective. We feel Elray Gaming meets the criteria, and we look forward to assisting them in expanding their corporate message to the investment community."

Read More >>

TechPrecision Corporation (OTCBB: TPCS)

TechPrecision Corporation Schedules Conference Call to Report Third Quarter Fiscal 2012 Financial Results

WESTMINSTER, Mass., Feb. 7, 2012 /PRNewswire/ — TechPrecision Corporation (OTC Bulletin Board: TPCS), an industry leading manufacturer of precision, large-scale fabricated and machined metal components and systems with customers in the alternative energy, cleantech, medical, nuclear, defense, aerospace and other commercial industries, today announced it will announce financial results for its third quarter of fiscal 2012, the period ended December 31, 2011, on Tuesday, February 14, 2012, after the market closes.

Read More >>

Spur Ventures Inc. (OTCBB: SPVEF)

Spur Shareholders Approve the Sale of Spur BVI to Hong Tang Vision Ltd For $9.25 Million

VANCOUVER, BRITISH COLUMBIA–(Marketwire – Feb. 7, 2012) – Spur Ventures Inc. ("Spur" or the "Company") (TSX:SVU)(OTCBB:SPVEF) is pleased to announce that the Company received shareholder approval at the Special Shareholders’ meeting held on February 7, 2012 in Vancouver for the proposed sale of its wholly-owned subsidiary, Spur Chemicals (BVI) Inc. ("Spur BVI") to Hong Tang Vision Ltd ("Hong Tang"), a limited liability company registered in the Cayman Islands for cash proceeds of $9.25 million.

Read More >>

Oracle Mining Corp. (OTCQX: OMCCF)

Oracle Mining Appoints Doug Nicholson as Chief Operating Officer

Mr. Nicholson will lead the Oracle Mining operations team in the re-start of the Oracle Ridge Copper Mine near Tucson, Arizona. He has extensive experience in the construction and management of mining operations in North America and will also be directly involved in all aspects of the Corporation’s strategic planning and business development.

Read More >>

Continental Prison Systems, Inc. (Pink Sheets: CPSZ)

Continental Prison Systems, Inc. (CPSZ) Continues Expanding Client Base in 2011

IRVINE, Calif., Feb. 8, 2012 (GLOBE NEWSWIRE) — Continental Prison Systems, Inc. (Pink Sheets:CPSZ), dba EZ Card & Kiosk, the industry leader in offering financial transaction services to the correctional and judicial markets in the US since 2008, is expanding aggressively leading into 2012 with the addition of seven county jail clients during 2011, representing an additional 2,600 ‘average daily population’ of inmates under the EZ Card & Kiosk suite of services.

Read More >>

Gold Dynamics Corp. (OTCQB: GLDN)

Gold Dynamics to Acquire Mining Properties in Canada

LAS VEGAS, NEVADA–(Marketwire – Feb. 8, 2012) – Gold Dynamics Corp. (GLDN) (OTCBB:GLDN)(OTCQB:GLDN) (http://www.golddynamics.com) announced today that it has entered into an agreement to acquire the Lake Ste-Anne property from Fayz Yacoub, P. Geo and Remy Yacoub.

Read More >>

American Energy Development Corp. (OTCBB: AEDC)

American Energy Development Corporation Announces $7,800,000 Financing With Institutional Investor

Joel Felix, Chief Financial Officer of American Energy Development Corp., said, "I’m delighted that we know we have capital backing to finance our long-term development strategy for the company. The equity investment structure will allow all funding received to be allocated to growing the company, while not burdening the company with servicing any debt."

Read More >>

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide. Known for its ability to help emerging growth companies build a following among retail and institutional investors, SmallCapVoice.com utilizes its stock newsletter to feature its audio interviews, as well small cap company’s financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our company information sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.

IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks

Contact:

Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
http://www.smallcapvoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

Viper Network shareholders and potential investors are encouraged to follow the Company’s progress closely and keep the symbol VPER on their watch list for more news announcements and press releases.

For additional information, please visit www.vipernetworks.com, www.LEDsAmerica.com and www.LEDOglobal.com.

Except for the historical information contained herein, this press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from the results predicted and reported results should not be considered an indication of future performance.

Contact:
Heritage First Capital
Scott Gibson, 407-444-5959

Contact for SmallCapVoice.com:
Stuart T. Smith
512-267-2430
info@smallcapvoice.com

SOURCE SmallCapVoice.com, Inc.

DELRAY BEACH, Fla., Feb. 7, 2012 (GLOBE NEWSWIRE) — PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today that it has commenced a clinical trial of its Easy Check™ non-invasive breath glucose detection device for people with diabetes. The clinical trial, being held at Schneider Children’s Medical Center in Israel, a preeminent research hospital, will initially focus on people with type 1 diabetes and the Company expects to begin recruiting subjects this month.

Currently under development in Israel, Easy Check is a non-invasive breath glucose detection device that measures the level of acetone in a patient’s exhaled breath and correlates that acetone level to a measure of blood glucose. The Easy Check technology is based on a patent-pending reagent cell that mixes a patient’s exhaled air with a proprietary chemical compound, triggering a chemical reaction. The reaction is measured and software in the Easy Check device then interprets the measurement and correlates the patient’s acetone level to the level of glucose in the body. The goal of Easy Check is to eliminate a patient’s need to prick his or her finger multiple times per day to get a blood sugar reading.

The purpose of the clinical study is to assess the feasibility of Easy Check compared to a standard invasive blood glucose meter and to assess the reliability of Easy Check in measuring blood glucose levels under conditions of altered blood glucose levels. The study will be led by principal investigator Moshe Phillip, Professor and Director of the Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes at Schneider Children’s Medical Center of Israel.

Prof. Phillip said, "We are eager to begin testing PositiveID’s Easy Check breath device with the hope that one day, Easy Check will offer a non-invasive way to follow the metabolic control of diabetes patients."

PositiveID Chairman and CEO William J. Caragol, said, "After previously announcing positive preliminary laboratory results from testing Easy Check in 2011, this independent clinical study is an important milestone in the advancement of Easy Check. We are very pleased that Prof. Phillip, a world renowned endocrinologist heavily involved in groundbreaking diabetes research, is spearheading this study and we look forward to communicating our progress."

The clinical study has been approved as compliant with the Declaration of Helsinki, which is a set of ethical principles regarding human experimentation developed for the medical community by the World Medical Association.

More than 25 million children and adults in the U.S. have diabetes, or over 8 percent of the population, according to the 2011 National Diabetes Fact Sheet. The CDC predicts that nearly 30 percent of children born after the year 2000 will develop diabetes. The lifetime risk of developing diabetes for those born in the year 2000 is 35 percent. The total cost of diagnosed diabetes in the U.S. is estimated at $200 billion.

Schneider Children’s is the only comprehensive, highly specialized care hospital of its kind in the country of Israel and in the Middle East, dedicated exclusively to the well-being of all children and adolescents. Schneider Children’s provides the full range of pediatric subspecialties and comprehensive paramedical services to all children. The medical center serves as the national referral center for Hematology-Oncology, Endocrinology and Childhood Diabetes, and Cardiology and is the country’s leading institution in the field of bone marrow and organ transplants, such as heart and lung, liver and kidney.

About PositiveID Corporation

PositiveID Corporation develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit www.PositiveIDCorp.com.

The PositiveID Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7717

Statements about PositiveID’s future expectations, including the likelihood that the Company expects to begin recruiting subjects for the Easy Check clinical trial this month; the likelihood that the reaction from exhaled breath is measured and software in the Easy Check device then interprets the measurement and correlates the patient’s acetone level to the level of glucose in the body; the likelihood that Easy Check will eliminate a patient’s need to prick his or her finger multiple times per day to get a blood sugar reading; the likelihood that, one day, Easy Check will offer a non-invasive way to follow the metabolic control of diabetes patients; the likelihood that PositiveID will communicate its progress with this clinical trial; the likelihood that nearly 30 percent of children born after the year 2000 will develop diabetes; the likelihood that the lifetime risk of developing diabetes for those born in the year 2000 is 35 percent; the likelihood the total cost of diagnosed diabetes in the U.S. is estimated at $200 billion; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include PositiveID’s ability to successfully complete this clinical trial of Easy Check; PositiveID’s ability to commercialize Easy Check; as well as certain other risks. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

CONTACT: Allison Tomek
561-805-8000
atomek@positiveidcorp.com

Source: Globe Newswire (February 7, 2012 – 4:15 PM EST)

Farid Shouekani Chief Executive Officer of Viper Networks, Inc. (Pink Sheets: VPER) called in to SmallCapVoice.com to discuss the company’s business model and latest news.

Viper Networks, Inc. (“Viper” or the “Company”), a Nevada corporation, was founded in September 2000 by a team of experienced entrepreneurs who have a successful track record in building both private and public companies. The Company is a full service integration and application services provider (“ASP”) of worldwide Voice over Internet Protocol (“VoIP”) telephony services, including the transmission of voice and data traffic for communications carriers and provision of enhanced Web-based and other communications services to businesses, institutions and ISPs. VoIP telephony is the real time transmission of voice communications in the form of digitized “packets” of information over the Internet or a private network, similar to the way in which e-mail and other data is transmitted. Viper specializes in the provision of VoIP telephony services and the cost-effective design, implementation, maintenance and management of network-based voice and data communications. Viper has been pioneering VoIP services and technology for more than nine years. For more information, please visit www.vipernetworks.com.

DELRAY BEACH, Fla., Feb. 7, 2012 (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or “Company”) (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today that it has commenced a clinical trial of its Easy Check™ non-invasive breath glucose detection device for people with diabetes. The clinical trial, being held at Schneider Children’s Medical Center in Israel, a preeminent research hospital, will initially focus on people with type 1 diabetes and the Company expects to begin recruiting subjects this month.

Currently under development in Israel, Easy Check is a non-invasive breath glucose detection device that measures the level of acetone in a patient’s exhaled breath and correlates that acetone level to a measure of blood glucose. The Easy Check technology is based on a patent-pending reagent cell that mixes a patient’s exhaled air with a proprietary chemical compound, triggering a chemical reaction. The reaction is measured and software in the Easy Check device then interprets the measurement and correlates the patient’s acetone level to the level of glucose in the body. The goal of Easy Check is to eliminate a patient’s need to prick his or her finger multiple times per day to get a blood sugar reading.

The purpose of the clinical study is to assess the feasibility of Easy Check compared to a standard invasive blood glucose meter and to assess the reliability of Easy Check in measuring blood glucose levels under conditions of altered blood glucose levels. The study will be led by principal investigator Moshe Phillip, Professor and Director of the Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes at Schneider Children’s Medical Center of Israel.

Prof. Phillip said, “We are eager to begin testing PositiveID’s Easy Check breath device with the hope that one day, Easy Check will offer a non-invasive way to follow the metabolic control of diabetes patients.”

PositiveID Chairman and CEO William J. Caragol, said, “After previously announcing positive preliminary laboratory results from testing Easy Check in 2011, this independent clinical study is an important milestone in the advancement of Easy Check. We are very pleased that Prof. Phillip, a world renowned endocrinologist heavily involved in groundbreaking diabetes research, is spearheading this study and we look forward to communicating our progress.”

The clinical study has been approved as compliant with the Declaration of Helsinki, which is a set of ethical principles regarding human experimentation developed for the medical community by the World Medical Association.

More than 25 million children and adults in the U.S. have diabetes, or over 8 percent of the population, according to the 2011 National Diabetes Fact Sheet. The CDC predicts that nearly 30 percent of children born after the year 2000 will develop diabetes. The lifetime risk of developing diabetes for those born in the year 2000 is 35 percent. The total cost of diagnosed diabetes in the U.S. is estimated at $200 billion.

Schneider Children’s is the only comprehensive, highly specialized care hospital of its kind in the country of Israel and in the Middle East, dedicated exclusively to the well-being of all children and adolescents. Schneider Children’s provides the full range of pediatric subspecialties and comprehensive paramedical services to all children. The medical center serves as the national referral center for Hematology-Oncology, Endocrinology and Childhood Diabetes, and Cardiology and is the country’s leading institution in the field of bone marrow and organ transplants, such as heart and lung, liver and kidney.

About PositiveID Corporation

PositiveID Corporation develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit www.PositiveIDCorp.com.

The PositiveID Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7717

Statements about PositiveID’s future expectations, including the likelihood that the Company expects to begin recruiting subjects for the Easy Check clinical trial this month; the likelihood that the reaction from exhaled breath is measured and software in the Easy Check device then interprets the measurement and correlates the patient’s acetone level to the level of glucose in the body; the likelihood that Easy Check will eliminate a patient’s need to prick his or her finger multiple times per day to get a blood sugar reading; the likelihood that, one day, Easy Check will offer a non-invasive way to follow the metabolic control of diabetes patients; the likelihood that PositiveID will communicate its progress with this clinical trial; the likelihood that nearly 30 percent of children born after the year 2000 will develop diabetes; the likelihood that the lifetime risk of developing diabetes for those born in the year 2000 is 35 percent; the likelihood the total cost of diagnosed diabetes in the U.S. is estimated at $200 billion; and all other statements in this press release other than historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include PositiveID’s ability to successfully complete this clinical trial of Easy Check; PositiveID’s ability to commercialize Easy Check; as well as certain other risks. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

CONTACT: Allison Tomek
561-805-8000
atomek@positiveidcorp.com

Wall St edges higher as Greece draws up bailout terms

Stocks traded edged higher on Tuesday as investors awaited the outcome of discussions on a bailout package for Greece that would help the country avoid a chaotic default.

Greek officials worked on the draft of a text on the 130-billion-euro bailout plan that will be put to political leaders for approval as strikers protesting against more austerity tussled with police outside parliament.

A light U.S. economic calendar this week shifted investor focus back to the euro zone. With the S&P 500 up 6.6 percent this year the market has grown cautious before Greek leaders put pen to paper on the terms of the deal.

Michael Sheldon, chief market strategist at RDM Financial in Westport, Connecticut, said the market was holding up well despite some profit taking as investors bet a deal would be completed.

"If investors thought the Greek talks were going to collapse, financial markets will be a lot weaker than they are," he said. But "a lasting solution continues to be something that is hard to come by."

Read More >>

Yesterday’s Top Performing Small Cap Stock:

AmeriLithium Corp. (OTCBB: AMEL)

AmeriLithium Corp. was a SmallCapVoice top performer closing up over 17% on trading volume of 518,662 shares.

AmeriLithium is a publicly traded (OTC Bulletin Board: AMEL), mining company committed to progressively developing into one of the leading American players in the global Lithium industry. The Company is headquartered in Henderson, Nevada. AmeriLithium has amassed a Lithium portfolio consisting of approximately 727,319 acres, including four Nevada-based projects nearby the only Lithium producing plant in the US, a project in Alberta, Canada, and a project in Western Australia.

Read More >>

Today’s SmallCapVoice.com Hot Stock to Watch:

Sino Payments, Inc. (OTCQB: SNPY)

Sino Payments Merger Partner TAP Signs New Large Contract With Wincor Nixdorf to Service 1,100 Stores in China for the World’s #1 Health & Beauty Retailer

TAP wholly owned subsidiary signs contract to provide services to 1100+ outlets in China

HONG KONG, Feb. 6, 2012 /PRNewswire/ — Sino Payments, Inc. (OTCQB: SNPY) a technology Company providing proprietary IP transactions processing services to the retail industry, today announced that as a follow on to the recently announced merger with TAP Investments Group, a TAP wholly owned subsidiary in the People’s Republic of China (PRC) has signed a contract worth over USD1.5 Million with Wincor Nixdorf for the provision of Helpdesk, Hardware, Software Maintenance, New Store Opening and IMAC services to the world #1 Health & Beauty retailer’s 1100+ retail outlets in the PRC. The contract services started on the 1st of January 2012 and will last until 31stDecember 2012.

Read More >>

Other Small Cap News

CytoSorbents Corporation (OTCBB: CTSO)

CytoSorbents to Exhibit at the 2012 Symposium of Intensive Medicine and Intensive Care

MONMOUTH JUNCTION, NJ–(Marketwire – Feb 7, 2012) – CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company using blood purification to treat life-threatening illnesses, announced that it will exhibit at the 2012 Symposium of Intensive Medicine and Intensive Care from February 22-24, 2012 in Bremen, Germany. CytoSorbents will be available to discuss its CytoSorb™ technology in Booth # A7 in the Bremen Exhibition and Conference Centre. This conference attracts an estimated 4,000 participants and is the largest independent German association event to focus on critical care and intensive care medicine.

Read More >>

PolyMedix, Inc. (OTCBB: PYMX)

PolyMedix to Present at the 14th Annual BIO CEO and Investor Conference

RADNOR, Pa., Feb. 7, 2012 (GLOBE NEWSWIRE) — PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing innovative therapeutic drugs to treat serious acute-care conditions, will be presenting at the 14th Annual BIO CEO and Investor Conference. The Conference, which is the largest investor conference focused on established and emerging publicly traded biotech companies, will take place February 13-14, 2012 at the Waldorf Astoria in New York, NY.

Read More >>

VisualMED Clinical Solutions Corp. (Pink Sheets: VMCS)

VisualMED to Gain Access to US Hospital Networks

Sales of Standalone Modules Could Reach Ten Million in First Year

RENO, NV–(Marketwire – Feb 7, 2012) – VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6) announces that its suite of medical intelligent software for hospitals has been adapted so that autonomous modules and applications can be used by clinical staff through the entertainment hardware which is to be found by the bedside of a growing number of facilities.

Read More >>

Colombia Crest Gold Corp. (Pink Sheets: ECRTF)

Colombia Crest Gold Provides Exploration Update and Annual Review

"The noteworthy events that occurred over the past year have changed the Company in a very positive way – namely the technical success at Arabia which began as a pure grass roots exploration play," commented Hans Rasmussen, President and CEO. "With a strong focus on discovering a porphyry gold system in the Middle Cauca Belt in Colombia, things are moving forward at a very encouraging rate. While we are drilling at Arabia, our team will continue to explore the 34,000 hectare land package within the Fredonia and Venecia agreements, and review new acquisitions in the belt."

Read More >>

The Automotive Resource Network Holdings (Pink Sheets: ARNH)

The Automotive Resource Network Holdings, Today Announced FINRA Has Approved the Requested Symbol Change ARNH That Now They Will Permanently Trade Under

The Automotive Resource Network Holdings announced today that all of their filings with FINRA are completed and they now have a new trade symbol. The symbol change ARNH from DGIN will take effect immediately and completes a list of filings including a reverse split and name change. CEO Kathleen Roberton said "With the announcement of our recent symbol change this now completes all of our outstanding actions that were filed with FINRA over 4 months ago." Roberton continued to say "I am glad all this is behind us. We {the company} are in a much better place now that we truly have our own identity. This has been a long time coming, yet we can now focus on the company, the future, our shareholders and our distributors."

Read More >>

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide. Known for its ability to help emerging growth companies build a following among retail and institutional investors, SmallCapVoice.com utilizes its stock newsletter to feature its audio interviews, as well small cap company’s financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our company information sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.

IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks

Contact:

Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
http://www.smallcapvoice.com